|Bid||2,885.00 x 0|
|Ask||2,886.00 x 0|
|Day's range||2,860.00 - 2,914.50|
|52-week range||116.50 - 3,507.00|
|Beta (5Y monthly)||0.66|
|PE ratio (TTM)||11.56|
|Earnings date||31 Jul 2020|
|Forward dividend & yield||2.10 (7.21%)|
|Ex-dividend date||01 Oct 2020|
|1y target est||3,825.26|
FTSE 100 shares with unbeatable economic moats are the best way to beat the market and build serious wealth, says Tom Rodgers.The post £25k to invest? I'd buy these 2 practically invincible FTSE 100 shares appeared first on The Motley Fool UK.
This Fool explains why he's betting big on this high-yield FTSE 100 dividend stock that also appears to be deeply undervalued after recent declines. The post A 7%-yielding FTSE 100 dividend stock I’m convinced will help me retire in luxury appeared first on The Motley Fool UK.
There is great comfort to be found in regular, reliable dividend payouts – especially in times of economic uncertainty. But finding shares that can pay them is...
British American Tobacco p.l.c. (LON:BATS) stock is about to trade ex-dividend in four days. This means that investors...
The worst of the stock market crash may be over, but Roland Head thinks that income investors can still pick up some high-yield bargains.The post Stock market crash bargains: I'd buy these cheap FTSE 100 dividend shares today appeared first on The Motley Fool UK.
Shares in British American Tobacco (LON:BATS) are currently trading at 3030.5 but the question for investors is how much the market chaos of 2020 will impact o...
Shares in British American Tobacco (LON:BATS) are currently trading at 3022.5 but a key question for investors is how the economic uncertainty caused by Covid-...
The best cheap shares to buy now? Quality companies selling at below fair value prices, of course. Rachael FitzGerald-Finch discusses two of them.The post Why I think these are two of the best cheap shares to buy now appeared first on The Motley Fool UK.
These two FTSE 100 (INDEXFTSE:UKX) shares could offer good value for money and long-term total return potential, in my opinion.The post Have £10k to invest in FTSE 100 stocks? I’d buy these 2 bargain shares in an ISA today appeared first on The Motley Fool UK.
Image source: The Motley Fool. British American Tobacco PLC (NYSE: BTI)Q1 2020 Earnings CallJun 9, 2020, 4:00 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Mike Nightingale -- Investor RelationsTo begin, I need to draw your attention to [Technical Issue]Thank you, and good morning, everyone.
(Bloomberg Opinion) -- So, perhaps reassuringly, it turned out tobacco wasn’t so defensive during this global health crisis after all.After indications early in the pandemic that tobacco may hold up, British American Tobacco Plc on Tuesday reduced its forecasts for full-year sales growth as Covid-19 lockdowns hurt business in emerging markets. The maker of Dunhill, Lucky Strike and Rothmans cigarettes depends on developing nations for one-quarter of its revenue.South Africa has banned sales of tobacco products as part of a strict lockdown policy that BAT and other companies are fighting. Cigarette consumption has been disrupted by curfews in some markets, such as Bangladesh. In addition, smoking in markets such as Vietnam often takes place in bars and restaurants. With establishments closed, or consumers reluctant to venture out, there was less temptation to light up.This slowdown provides good reason for pause for investors in BAT, led by the relatively new Chief Executive Officer Jack Bowles. With higher smoking rates, and the potential for consumers to trade up to more expensive brands as average incomes grow, these regions are supposed to offset the deterioration in developed markets as people there quit smoking. But now, because of the coronavirus hit, BAT expects a 7% decline in global industry sales volumes of cigarettes and heated-tobacco devices this year, more than the previously anticipated 5% fall.This scenario has implications for competitors such as Philip Morris International Inc. and Japan Tobacco Inc., which produces Winston and Benson & Hedges cigarettes. Japan Tobacco has been using its strong balance sheet to buy emerging-market brands over the past few years.As the contagion spread and shined a spotlight on potential risks related to smoking, lockdowns meant BAT had to delay launches of new devices that heat rather than burn tobacco and electronic cigarettes, because the stores where they’re sold were shut. The U.S. market, the world’s biggest for electronic cigarettes, was already struggling to recover after a spate of illnesses and deaths last year related to vaping.Consequently, BAT expects to reach its target of annual sales of 5 billion pounds ($6.4 billion) from tobacco alternatives a year later than planned, in 2025. The dislocation across cigarettes and newer products will lead to lower underlying earnings growth this year than previously forecast, as well as a slower reduction in debt.However, it’s still too early to throw out the thesis that people will reach for cigarettes no matter what’s happening. In developed markets, consumption is holding up. In the U.S., for example, industry volumes could now fall by only about 4% this year, compared with the 5% previously anticipated, amid signs pointing to BAT gaining market share and few consumers are switching to cheaper brands.Vaping as a category is still reeling, but BAT is making headway with its Vuse and Vype brands. And it continues to invest in its tobacco heating device Glo, as well as in oral tobacco Velo. The strategy of having a balanced portfolio of new-generation products is wise. It’s not yet clear which of these categories will be the winner as traditional cigarette sales decline.True, BAT had to lower its outlook and there is a risk that smokers will seek out cheaper brands in a recession, but at least the company is updating investors regularly. It also remains committed to its policy of paying out 65% of underlying earnings per share. Rival Imperial Brands Plc cut its dividend last month.BAT has not been immune from the pandemic, but the company is positioning itself well for the future. And who knows, its biotech subsidiary might even come up with a Covid-19 vaccine.This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Andrea Felsted is a Bloomberg Opinion columnist covering the consumer and retail industries. She previously worked at the Financial Times.For more articles like this, please visit us at bloomberg.com/opinionSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
The British American Tobacco share price has dipped today, but this could be an opportunity to buy this top FTSE 100 income stock.The post Looking for a 7% yield? Then I'd buy the British American Tobacco share price today appeared first on The Motley Fool UK.
Shares in the world's second largest cigarette maker fell almost 4% after it lowered revenue and profit growth estimates for this year by a couple of percentage points each. Big developing markets including South Africa, where tobacco sales have been banned since March, have extended restrictions, while curbs have also continued on bars in countries including Vietnam. Marlboro maker Altria pulled its forecast for the current financial year in April, but along with Gauloises maker Imperial Brands has so far given little guidance on the impact of the lockdowns on demand for the rest of the year.
A daily overview of the top business, market, and economic stories you should be watching today in the UK, Europe, and around the world.
BAT said longer-than-expected lockdowns in markets like South Africa, Mexico, and Argentina had contributed to disappointing sales in emerging markets.
HSBC <HSBA.L> fell 3.6% and was the biggest weight on the FTSE 100 index <.FTSE> after Aviva Investors, a top-20 investor in both the bank and peer Standard Chartered <STAN.L>, raised concerns over their support for the law. The blue-chip FTSE 100 declined 2.1%, with cigarette maker British American Tobacco Plc <BATS.L> falling 3.1% after it flagged a demand hit due to prolonged lockdowns in South Africa and Mexico and weak sales in Bangladesh and Vietnam.
Neil Woodford investors have been locked in for a year, losing money. I think he should have kept this old-school value share.The post Burned by Neil Woodford? I'd buy this FTSE 100 cash payout of 6.5% today! appeared first on The Motley Fool UK.
The compounding effects of reinvesting dividends over the long-term can be spectacular - but finding stocks to help you do it is a challenge... The present eco...
It's more than a year since Neil Woodford shut down his Equity Income Fund. Roland Head picks three value stocks he'd buy with cash from the fund.The post Forget Neil Woodford. I think these are the best UK stocks to buy today appeared first on The Motley Fool UK.
Tobacco vaccine production is a surprisingly economical endeavor, saving time and costs. Kentucky Bioprocessing, the biotechnology subsidiary of British American Tobacco, is leading the way.
British American Tobacco (NYSE: BTI) is a London-based company, but its acquisition of Reynolds American in 2017 gave BAT the No. 2 position in U.S. cigarette market share. At this point, BAT's declines have made it look especially attractive to value investors, but prospective buyers want to know whether they're getting themselves into a value trap. Below, we'll look more closely at British American Tobacco and whether its stock is a good buy.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Although there are many companies pursuing a vaccine for COVID-19, the tobacco industry may be one of the more surprising combatants in this battle. Both British American Tobacco (NYSE: BTI) and Philip Morris International (NYSE: PM) are working on a vaccine for the disease. Unlike automakers or cosmetics companies converting production facilities to make personal protective equipment, it's not the actual manufacturing units of the tobacco companies working to fight COVID-19, but rather their biotech divisions.
Quality and momentum are highly prized among investors looking for reliable investment ideas. That's because good quality stocks tend to be resilient, cash-gen...